Justice Department Briefing 2026-11-02
Estimated reading time: 3 minutes
1. Annual Determination of Average Cost of Incarceration Fee (COIF)
Sub: Justice Department, Prisons Bureau
Content: This Notice publishes the Fiscal Year (FY) 2025 Cost of Incarceration Fee (COIF) for Federal inmates.
2. Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences
Sub: Justice Department, Drug Enforcement Administration
Content: AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
3. Importer of Controlled Substances Application: Globyz Pharma LLC
Sub: Justice Department, Drug Enforcement Administration
Content: Globyz Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
4. Conforming Amendment Regarding the Criminal Law Technical Amendments Act of 2002
Sub: Justice Department, Drug Enforcement Administration
Content: The Criminal Law Technical Amendments Act of 2002 ("Technical Amendments Act") became law on November 2, 2002, as part of the 21st Century Department of Justice Appropriations Authorization Act. The Technical Amendments Act amended sections 401(d), 402(c), and 403 of the Controlled Substances Act by replacing outmoded fine amounts with a reference to title 18 of the United States Code in each place that a specific fine amount had appeared. In this rulemaking, the Drug Enforcement Administration (DEA) is amending its regulations to conform them to the statutory amendments made to the Controlled Substances Act by the Technical Amendments Act.
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.
